{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:06:11Z","timestamp":1790805971906,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010090","name":"Women and Children's Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010090","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Friends of Garrett Cumming Research Fund"},{"DOI":"10.13039\/501100000223","name":"Muscular Dystrophy Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000223","id-type":"DOI","asserted-by":"publisher"}]},{"name":"HM Toupin Neurological Science Research Fund"},{"name":"Canadian Institutes of Health Research China-Canada Joint Health Research Initiative","award":["132574"],"award-info":[{"award-number":["132574"]}]},{"name":"Foundation Grant","award":["143251"],"award-info":[{"award-number":["143251"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canada Foundation for Innovation Infrastructure Operating Fund","award":["30819"],"award-info":[{"award-number":["30819"]}]},{"name":"Alberta Enterprise and Advanced Education"},{"name":"Jesse\u2019s Journey - Foundation for Gene and Cell Therapy"},{"DOI":"10.13039\/100005693","name":"Parent Project Muscular Dystrophy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ymthe.2018.10.011","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T04:00:52Z","timestamp":1540008052000},"page":"76-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates"],"prefix":"10.1016","volume":"27","author":[{"given":"Kenji Rowel Q.","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Echigoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsuki","family":"Kuraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Partridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin\u2019ichi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2018.10.011_bib1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2018.10.011_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymthe.2018.10.011_bib3","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/adc.2007.118141","article-title":"Update on the management of Duchenne muscular dystrophy","volume":"93","author":"Manzur","year":"2008","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymthe.2018.10.011_bib4","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nrg1180","article-title":"Advances in Duchenne muscular dystrophy gene therapy","volume":"4","author":"van Deutekom","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2018.10.011_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbadis.2006.05.010","article-title":"Dystrophin, its interactions with other proteins, and implications for muscular dystrophy","volume":"1772","author":"Ervasti","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2018.10.011_bib6","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.122.4.809","article-title":"A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin","volume":"122","author":"Ervasti","year":"1993","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ymthe.2018.10.011_bib7","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2147\/NDT.S93873","article-title":"Current and emerging treatment strategies for Duchenne muscular dystrophy","volume":"12","author":"Mah","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.ymthe.2018.10.011_bib8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0888-7543(88)90113-9","article-title":"An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus","volume":"2","author":"Monaco","year":"1988","journal-title":"Genomics"},{"key":"10.1016\/j.ymthe.2018.10.011_bib9","first-page":"498","article-title":"The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion","volume":"45","author":"Koenig","year":"1989","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2018.10.011_bib10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1073\/pnas.98.1.42","article-title":"Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse","volume":"98","author":"Mann","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2018.10.011_bib11","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/hmg\/ddg196","article-title":"Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle","volume":"12","author":"Gebski","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2018.10.011_bib12","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nm897","article-title":"Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse","volume":"9","author":"Lu","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2018.10.011_bib13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1073\/pnas.0406700102","article-title":"Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles","volume":"102","author":"Lu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2018.10.011_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.21627","article-title":"Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs","volume":"65","author":"Yokota","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2018.10.011_bib15","first-page":"179","article-title":"Optimizing exon skipping therapies for DMD","volume":"26","author":"Yokota","year":"2007","journal-title":"Acta Myol."},{"key":"10.1016\/j.ymthe.2018.10.011_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/nat.2013.0451","article-title":"Skipping multiple exons of dystrophin transcripts using cocktail antisense oligonucleotides","volume":"24","author":"Echigoya","year":"2014","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.ymthe.2018.10.011_bib17","unstructured":"U.S. Food and Drug Administration (2016). FDA grants accelerated approval to first\u00a0drug for Duchenne muscular dystrophy. https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm521263.htm."},{"key":"10.1016\/j.ymthe.2018.10.011_bib18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/DDDT.S97635","article-title":"Eteplirsen in the treatment of Duchenne muscular dystrophy","volume":"11","author":"Lim","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ymthe.2018.10.011_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/nat.2016.0657","article-title":"FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga","volume":"27","author":"Aartsma-Rus","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.ymthe.2018.10.011_bib20","unstructured":"Sarepta Therapeutics (2017). Sarepta Therapeutics Announces Positive Results in Its Study Evaluating Gene Expression, Dystrophin Production, and Dystrophin Localization in Patients with Duchenne Muscular Dystrophy (DMD) Amenable to\u00a0Skipping Exon 53 Treated with Golodirsen (SRP-4053). https:\/\/globenewswire.com\/news-release\/2017\/09\/06\/1108211\/0\/en\/Sarepta-Therapeutics-Announces-Positive-Results-in-Its-Study-Evaluating-Gene-Expression-Dystrophin-Production-and-Dystrophin-Localization-in-Patients-with-Duchenne-Muscular-Dystrop.html."},{"key":"10.1016\/j.ymthe.2018.10.011_bib21","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/mt.2010.186","article-title":"In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse","volume":"18","author":"Aoki","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.10.011_bib22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/mus.10319","article-title":"Early prednisone treatment in Duchenne muscular dystrophy","volume":"27","author":"Merlini","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2018.10.011_bib23","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/mus.23272","article-title":"Early corticosteroid treatment in 4 Duchenne muscular dystrophy patients: 14-year follow-up","volume":"45","author":"Merlini","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2018.10.011_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1474-4422(14)70318-7","article-title":"Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial","volume":"14","author":"Raman","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymthe.2018.10.011_bib25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCULATIONAHA.111.031716","article-title":"Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice","volume":"124","author":"Rafael-Fortney","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2018.10.011_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1538\/expanim.52.93","article-title":"Canine X-linked muscular dystrophy in Japan (CXMDJ)","volume":"52","author":"Shimatsu","year":"2003","journal-title":"Exp. Anim."},{"key":"10.1016\/j.ymthe.2018.10.011_bib27","first-page":"1314","article-title":"Dystrophin-deficient large animal models: translational research and exon skipping","volume":"7","author":"Yu","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ymthe.2018.10.011_bib28","doi-asserted-by":"crossref","first-page":"e12239","DOI":"10.1371\/journal.pone.0012239","article-title":"Antisense PMO found in dystrophic dog model was effective in cells from exon 7-deleted DMD patient","volume":"5","author":"Saito","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.10.011_bib29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1089\/nat.2012.0368","article-title":"Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs","volume":"22","author":"Yokota","year":"2012","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.ymthe.2018.10.011_bib30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/15476286.2015.1125074","article-title":"Non-sequential and multi-step splicing of the dystrophin transcript","volume":"13","author":"Gazzoli","year":"2016","journal-title":"RNA Biol."},{"key":"10.1016\/j.ymthe.2018.10.011_bib31","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1161\/CIRCULATIONAHA.107.739326","article-title":"Selective vacuolar degeneration in dystrophin-deficient canine Purkinje fibers despite preservation of dystrophin-associated proteins with overexpression of Dp71","volume":"117","author":"Urasawa","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2018.10.011_bib32","first-page":"184","article-title":"The role of fibrosis in Duchenne muscular dystrophy","volume":"31","author":"Klingler","year":"2012","journal-title":"Acta Myol."},{"key":"10.1016\/j.ymthe.2018.10.011_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13395-015-0070-6","article-title":"Elusive sources of variability of dystrophin rescue by exon skipping","volume":"5","author":"Vila","year":"2015","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ymthe.2018.10.011_bib34","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/srep02183","article-title":"Initial pulmonary respiration causes massive diaphragm damage and hyper-CKemia in Duchenne muscular dystrophy dog","volume":"3","author":"Nakamura","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2018.10.011_bib35","first-page":"1475","article-title":"Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options","volume":"11","author":"LoMauro","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ymthe.2018.10.011_bib36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/jnnp-2013-306350","article-title":"Dystrophin levels and clinical severity in Becker muscular dystrophy patients","volume":"85","author":"van den Bergen","year":"2014","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymthe.2018.10.011_bib37","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1096\/fj.12-224170","article-title":"Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin\/utrophin double-knockout mice","volume":"27","author":"van Putten","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2018.10.011_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/archneurol.2008.540","article-title":"A renaissance for antisense oligonucleotide drugs in neurology: exon skipping breaks new ground","volume":"66","author":"Yokota","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymthe.2018.10.011_bib39","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1093\/hmg\/ddt341","article-title":"Highly efficient in\u00a0vivo delivery of PMO into regenerating myotubes and rescue in laminin-\u03b12 chain-null congenital muscular dystrophy mice","volume":"22","author":"Aoki","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2018.10.011_bib40","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41467-017-00924-7","article-title":"Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle","volume":"8","author":"Novak","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2018.10.011_bib41","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1073\/pnas.1613203114","article-title":"Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy","volume":"114","author":"Echigoya","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2018.10.011_bib42","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.bbamem.2010.02.012","article-title":"Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy","volume":"1798","author":"Moulton","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2018.10.011_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2261-6-47","article-title":"Cardiac involvement in\u00a0Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies","volume":"6","author":"Yugeta","year":"2006","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ymthe.2018.10.011_bib44","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1093\/nar\/gkw236","article-title":"The delivery of therapeutic oligonucleotides","volume":"44","author":"Juliano","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2018.10.011_bib45","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1093\/nar\/gkt1220","article-title":"Cellular trafficking determines the exon skipping activity of Pip6a-PMO in mdx skeletal and cardiac muscle cells","volume":"42","author":"Lehto","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2018.10.011_bib46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/bc060138s","article-title":"Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells","volume":"18","author":"Youngblood","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ymthe.2018.10.011_bib47","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1038\/mtna.2012.18","article-title":"Peptide-mediated Cell and In\u00a0Vivo Delivery of Antisense Oligonucleotides and siRNA","volume":"1","author":"J\u00e4rver","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2018.10.011_bib48","first-page":"e53776","article-title":"Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy","volume":"111","author":"Miskew Nichols","year":"2016","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ymthe.2018.10.011_bib49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-4939-6817-6_17","article-title":"Systemic Delivery of Morpholinos to Skip Multiple Exons in a Dog Model of Duchenne Muscular Dystrophy","volume":"1565","author":"Maruyama","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2018.10.011_bib50","first-page":"145","article-title":"Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ","volume":"24","author":"Shimatsu","year":"2005","journal-title":"Acta Myol."},{"key":"10.1016\/j.ymthe.2018.10.011_bib51","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.nmd.2010.02.004","article-title":"A 3\u00a0months mild functional test regime does not affect disease parameters in young mdx mice","volume":"20","author":"van Putten","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2018.10.011_bib52","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/nat.2014.0528","article-title":"Development and Application of an Ultrasensitive Hybridization-Based ELISA Method for the Determination of Peptide-Conjugated Phosphorodiamidate Morpholino Oligonucleotides","volume":"25","author":"Burki","year":"2015","journal-title":"Nucleic Acid Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618305008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618305008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:54:00Z","timestamp":1761501240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001618305008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1525001618305008"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.10.011","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}